BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 11
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews
©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 110202
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110202
Table 3 ADAM metallopeptidase with thrombospondin type 1 motif 8, kallikrein-related peptidases 10 and 5 in some human cancers
Cancer
Expression of ADAMTS-8
Expression of KLK10
Expression of KLK5
Breast cancer111
Prostate cancer--2
Testicular cancer-22
Vaginal cancer--2
Ovarian cancer-23
Gastric cancer213
Brain cancer2--
Lung cancer22-
Colorectal cancer23-
Esophageal squamous cell carcinoma2--
Hepatocellular carcinoma2--
Esophageal cancer-2-
Acute lymphoblastic leukemia-2-
Skin cancer-33
Colon cancer-3-
Pancreatic cancer-3-
Oral squamous cell carcinoma--1
Urinary bladder carcinoma cells--3
1Indicates dual function.
2Indicates downregulation with function as a tumor suppressor.
3Indicates overexpression with protumoral properties.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.